Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Change in Cash (2016 - 2025)

Bio Key International's Change in Cash history spans 16 years, with the latest figure at -$235492.0 for Q3 2025.

  • For Q3 2025, Change in Cash fell 143.55% year-over-year to -$235492.0; the TTM value through Sep 2025 reached $238716.0, down 84.02%, while the annual FY2024 figure was -$73796.0, 96.53% up from the prior year.
  • Change in Cash for Q3 2025 was -$235492.0 at Bio Key International, up from -$858407.0 in the prior quarter.
  • Across five years, Change in Cash topped out at $2.7 million in Q1 2025 and bottomed at -$3.5 million in Q1 2021.
  • The 5-year median for Change in Cash is -$858407.0 (2025), against an average of -$787012.8.
  • The largest annual shift saw Change in Cash plummeted 1011.7% in 2021 before it surged 1405.82% in 2025.
  • A 5-year view of Change in Cash shows it stood at -$1.8 million in 2021, then surged by 92.43% to -$139095.0 in 2022, then soared by 246.89% to $204314.0 in 2023, then tumbled by 767.37% to -$1.4 million in 2024, then skyrocketed by 82.73% to -$235492.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Change in Cash are -$235492.0 (Q3 2025), -$858407.0 (Q2 2025), and $2.7 million (Q1 2025).